Similarly, ECs treated with serum of HF patients, which contained higher KMV levels, exhibited decreases of EdU incorporation, wound closure, tube formation, and VEGF and Ang-1 expression (Figure S5A-E). The gene discussed is VEGFA; the disease is hydrops fetalis.